That is the conclusion of Professor Harry Bartelink, from the Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital (NKI-AVL) in Amsterdam, and his colleagues in the August issue of the top oncology journal Journal of Clinical Oncology.
During this randomized study, more than 5000 breast cancer patients were followed for 10 years. The research is a collaboration between the NKI-AVL and 32 other European research institutes, lead by Professor Harry Bartelink.
In the Netherlands, about 1 in 9 women get breast cancer. Breast cancer is therefore the most common cancer in women. Approximately 80% of the women are treated with breast conserving surgery.
Professor Harry Bartelink and his colleagues followed breast cancer patients who received two doses of irradiation after surgery: a dose of 50 Gy, followed by an extra “boost” dose of 16 Gy. The boost dose lead to a 40% reduction in the chance of tumor recurrence after breast conserving surgery. The largest gain was shown for young women with breast cancer. Another important point is that with this treatment more than 80% of the patients are alive at 10 years after treatment.
Bartelink: “The favourable treatment results are partly due to the strict quality control that the participating centers had to adhere to. The outcome of this trial has lead to a worldwide change in the treatment policy for women with breast cancer”.
In a new Dutch collaboration the Professor of Radiotherapy has started a large study where he hopes to further improve the treatment results for young women with breast cancer. At the same time, ways to use modern molecular techniques for predicting sensitivity to radiation are being investigated.
Frederique Melman | Source: alphagalileo
Further information: www.nki.nl
More articles from Studies and Analyses:
Study Shows Sweetener Marketing Tactics May Mislead Consumers
20.11.2009 | Corn Refiners Association
Debt Stress Drops for Third Straight Month, Survey Finds
20.11.2009 | Ohio State University
Scientists Unravel Evolution of Highly Toxic Box Jellyfish
20.11.2009 | Life Sciences
When good companies do bad things: Examining illegal corporate behavior
20.11.2009 | Business and Finance
UCR plant scientist's research spawns new discoveries showing how crops survive drought
20.11.2009 | Agricultural and Forestry Science
Multidisciplinary meeting on Urological Cancers aims to benefit cancer patients
20.11.2009 | Event News
'Golden Age' for clinical psychology in Northern Ireland
20.11.2009 | Event News
New Perspectives in Marine Anti-Fouling Research
11.11.2009 | Event News